Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C23H25O12.Cl |
| Molecular Weight | 528.89 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 5 / 5 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[Cl-].COC1=CC(=CC(OC)=C1O)C2=[O+]C3=C(C=C2O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C(O)=CC(O)=C3
InChI
InChIKey=YDIKCZBMBPOGFT-DIONPBRTSA-N
InChI=1S/C23H24O12.ClH/c1-31-14-3-9(4-15(32-2)18(14)27)22-16(7-11-12(26)5-10(25)6-13(11)33-22)34-23-21(30)20(29)19(28)17(8-24)35-23;/h3-7,17,19-21,23-24,28-30H,8H2,1-2H3,(H2-,25,26,27);1H/t17-,19-,20+,21-,23-;/m1./s1
| Molecular Formula | ClH |
| Molecular Weight | 36.461 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C23H24O12 |
| Molecular Weight | 492.4295 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 5 / 5 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Malvidin-3-O-glucoside is a polyphenolic anthocyanin. Anthocyanins are flavonoids widely distributed in fruits and vegetables that exhibit antioxidative and anti-inflammatory bioactivities. Among other polyphenolic components, malvidin-3-glucoside is present in ViNitrox™ a natural dietary supplement from apple and grape, it offers a number of exceptional sports nutrition properties including enhanced and lasting performance.
CNS Activity
Sources: https://www.ncbi.nlm.nih.gov/pubmed/19663426 | https://www.ncbi.nlm.nih.gov/pubmed/26235983
Curator's Comment: In combination, quercetin and malvidin-3-glucoside significantly attenuated sleep deprivation-induced cognitive impairment in -a mouse model of acute sleep deprivation. However, malvidin-3-glucoside was not detectable in the mouse brain after oral administration of bilberry extract containing anthocyanins including malvidin-3-glucoside.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: WP408 Sources: https://www.ncbi.nlm.nih.gov/pubmed/27935050 |
|||
Target ID: GO:0006954 |
|||
Target ID: CHEMBL1827 Sources: https://www.ncbi.nlm.nih.gov/pubmed/15769121 |
35.4 µM [IC50] |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | ViNitrox Approved UseViNitrox™ is a natural dietary supplement containing apple and grape polyphenols including proanthocyanidins (as catechins, B2 dimer), phenolic acids (as chlorogenic acids, gallic acids) and anthocyanins (as malvidin-3-glucoside). It offers a number of exceptional sports nutrition properties including enhanced and lasting performance. |
|||
| Primary | Unknown Approved UseUnknown |
Cmax
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
1.38 nM EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/11697443/ |
68.6 mg single, oral dose: 68.6 mg route of administration: Oral experiment type: SINGLE co-administered: |
MALVIDIN 3-GLUCOSIDE plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: FED |
AUC
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
288 nM × h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/11697443/ |
68.6 mg single, oral dose: 68.6 mg route of administration: Oral experiment type: SINGLE co-administered: |
MALVIDIN 3-GLUCOSIDE plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: FED |
Overview
| CYP3A4 | CYP2C9 | CYP2D6 | hERG |
|---|---|---|---|
OverviewOther
| Other Inhibitor | Other Substrate | Other Inducer |
|---|---|---|
Drug as perpetrator
| Target | Modality | Activity | Metabolite | Clinical evidence |
|---|---|---|---|---|
| no | ||||
| yes [IC50 43 uM] | ||||
| yes [IC50 70 uM] |
Drug as victim
| Target | Modality | Activity | Metabolite | Clinical evidence |
|---|---|---|---|---|
| no | ||||
| no | ||||
| no | ||||
| no | ||||
| no |
Tox targets
| Target | Modality | Activity | Metabolite | Clinical evidence |
|---|---|---|---|---|
PubMed
| Title | Date | PubMed |
|---|---|---|
| Stilbenes and anthocyanins reduce stress signaling in BV-2 mouse microglia. | 2013-06-26 |
|
| Malvidin-3-glucoside protects endothelial cells up-regulating endothelial NO synthase and inhibiting peroxynitrite-induced NF-kB activation. | 2012-09-30 |
|
| Bioassay-guided separation of an alpha-amylase inhibitor anthocyanin from Vaccinium arctostaphylos berries. | 2010-12-09 |
|
| Antioxidant activity of wine pigments derived from anthocyanins: hydrogen transfer reactions to the dpph radical and inhibition of the heme-induced peroxidation of linoleic acid. | 2009-07-08 |
|
| Anthocyanins in aged blueberry-fed rats are found centrally and may enhance memory. | 2005-04 |
|
| In vitro inhibition of human cGMP-specific phosphodiesterase-5 by polyphenols from red grapes. | 2005-03-23 |
|
| The anthocyanidins cyanidin and delphinidin are potent inhibitors of the epidermal growth-factor receptor. | 2001-02 |
Patents
Sample Use Guides
Vinitrox™, supplied by Nexira (France) is a combination of specific profile polyphenols from grape and apple. Vinitrox™ is a purified extract with low lipids, fibers and proteins content (respectively 0.5%, 1.4% and 5.5%) and more than 60% of total polyphenols (Folin method—expressed as gallic acid equivalent) with antioxidant properties demonstrated by ORAC value (12,000 μMtrolox equivalent per gram of ingredient). The main polyphenol classes are proanthocyanidins (as catechins, B2 dimer), phenolic acids (as chlorogenic acids, gallic acids) and anthocyanins (as malvidin-3-glucoside). Nexira’s latest clinical study on 50 athletes, 25-45 years old, demonstrated that under intensive effort, 500 mg/day of ViNitrox™ improves physical capabilities: increases physical training time by 10%, delays the fatigue barrier by 13%.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/23731018
1 mg/mL blueberry extract significantly reduced LPS-induced nitric oxide release in BV-2 mouse microglia; this concentration of blueberry extract contains 2.6 μM malvidin-3-O-glucoside, but when malvidin-3-O-glucoside was tested individually, 20 μM was necessary to observe a significant reduction in nitric oxide release.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 20:25:25 GMT 2025
by
admin
on
Mon Mar 31 20:25:25 GMT 2025
|
| Record UNII |
B34F52D7NB
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
OENIN
Created by
admin on Mon Mar 31 20:25:25 GMT 2025 , Edited by admin on Mon Mar 31 20:25:25 GMT 2025
|
PRIMARY | |||
|
70532
Created by
admin on Mon Mar 31 20:25:25 GMT 2025 , Edited by admin on Mon Mar 31 20:25:25 GMT 2025
|
PRIMARY | |||
|
B34F52D7NB
Created by
admin on Mon Mar 31 20:25:25 GMT 2025 , Edited by admin on Mon Mar 31 20:25:25 GMT 2025
|
PRIMARY | |||
|
31799
Created by
admin on Mon Mar 31 20:25:25 GMT 2025 , Edited by admin on Mon Mar 31 20:25:25 GMT 2025
|
PRIMARY | |||
|
11249520
Created by
admin on Mon Mar 31 20:25:25 GMT 2025 , Edited by admin on Mon Mar 31 20:25:25 GMT 2025
|
PRIMARY | |||
|
DTXSID301028795
Created by
admin on Mon Mar 31 20:25:25 GMT 2025 , Edited by admin on Mon Mar 31 20:25:25 GMT 2025
|
PRIMARY | |||
|
230-631-9
Created by
admin on Mon Mar 31 20:25:25 GMT 2025 , Edited by admin on Mon Mar 31 20:25:25 GMT 2025
|
PRIMARY | |||
|
7228-78-6
Created by
admin on Mon Mar 31 20:25:25 GMT 2025 , Edited by admin on Mon Mar 31 20:25:25 GMT 2025
|
PRIMARY |